C12Y 601/01006
Lysine-trna ligase
Official title: Lysine-tRNA ligase (6.1.1.6)
C12Y601/01006 (Lysine-trna ligase) appears on 7 US grants and 11 published applications in this corpus.
Search patents in C12Y- Granted patents
- 7
- Published applications
- 11
- Assignees
- 11
- Inventors
- 28
- Latest grant
- 28 Oct 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2002 | 1 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 1 |
| 2012 | 0 | 0 |
| 2013 | 0 | 1 |
| 2014 | 1 | 0 |
| 2015 | 0 | 1 |
| 2016 | 1 | 0 |
| 2017 | 0 | 2 |
| 2018 | 1 | 1 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 1 | 0 |
| 2022 | 0 | 3 |
| 2023 | 1 | 0 |
| 2024 | 0 | 0 |
| 2025 | 1 | 1 |
| 2026 | 0 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Aminoacyl-tRNA synthetase efficiently introducing lysine derivatives28 Oct 2025US 12,454,715 B2Suzhou Kunpeng Biotech Co., Ltd.
- Peptide for enhancing expression efficiency of target protein, and fusion protein comprising same28 Feb 2023US 11,591,630 B2Inthera Inc.
- Transgenic mouse capable of spatial and temporal control of expression and site-specific modification of target protein, production method and uses thereof2 Feb 2021US 10,905,107 B2Korea Advanced Institute of Science and Technology
- Method for controlling cancer metastasis or cancer cell migration by modulating the cellular level of lysyl tRNA synthetase27 Nov 2018US 10,139,394 B2Medicinal Bioconvergence Research Center
- Method for controlling cancer metastasis or cancer cell migration by modulating the cellular level of lysyl tRNA synthetase6 Dec 2016US 9,511,085 B2Medicinal Bioconvergence Research Center
- Recombinant expression vector for production of virus-like particle-based multivalent norovirus vaccine and manufacturing method therefor24 Sep 2026US 2026/0284173 A1Inthera Inc.
- Nanoparticles comprising fusion protein of single-chain variable fragment and ferritin, and use thereof6 Mar 2025US 2025/0075003 A1Research & Business Foundation Sungkyunkwan University
- Aminoacyl-trna synthetase efficiently introducing lysine derivatives15 Sep 2022US 2022/0290202 A1Suzhou Kunpeng Biotech Co., Ltd.
- Aminoacyl-trna synthetase for efficiently introducing lysine derivative in protein2 Jun 2022US 2022/0170030 A1Ningbo Kunpeng Biotech Co., Ltd.
- Novel peptide for enhancing expression efficiency of target protein, and fusion protein comprising same10 Feb 2022US 2022/0042063 A1Inthera Inc.
Most cited
By later US patents
- Monomeric forms of human aminoacyl-t-RNA synthetases having non-canonical biological activities2US 8,828,685 B2The Scripps Research Institute · 2014
- Method for controlling cancer metastasis or cancer cell migration by modulating the cellular level of lysyl tRNA synthetase2US 9,511,085 B2Medicinal Bioconvergence Research Center · 2016